Growth Metrics

Palisade Bio (PALI) Return on Equity (2011 - 2026)

Palisade Bio (PALI) reported Return on Equity of 0.0% for Q1 2026, up 2.0% year-over-year from 0.0% in Q1 2025, and up 24.23% on a QoQ basis from 0.0% in Q4 2025.

Palisade Bio (PALI) has 16 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

  • Quarterly Return on Equity rose 2.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (up 2.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
  • Return on Equity rose to 0.0% in Q1 2026 per PALI's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q1 2026 and bottomed at 0.07% in Q1 2022.
  • The 5-year median for Return on Equity is 0.01% (2024), against an average of 0.02%.
  • Peak annual rise in Return on Equity reached 7 bps in 2022, while the deepest fall reached 18 bps in 2022.
  • Tracing PALI's Return on Equity over 5 years: stood at 0.01% in 2022, then rose by 18 bps to 0.01% in 2023, then tumbled by 105 bps to 0.02% in 2024, then jumped by 87 bps to 0.0% in 2025, then grew by 24 bps to 0.0% in 2026.
  • Per Business Quant, the three latest PALI Return on Equity figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.04% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -0.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -0.01%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.00%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.01%
10 Palisade Bio 439.25 Mn 309.68 Mn - 0.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 -0.04%
Jun 30, 2025 -0.03%
Mar 31, 2025 -0.02%
Dec 31, 2024 -0.02%
Sep 30, 2024 -0.02%
Jun 30, 2024 -0.01%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.01%
Sep 30, 2023 -0.01%
Jun 30, 2023 -0.01%
Mar 31, 2023 -0.01%
Dec 31, 2022 -0.01%
Sep 30, 2022 -0.02%
Jun 30, 2022 -0.03%
Mar 31, 2022 -0.07%
Dec 31, 2021 -0.08%
Sep 30, 2021 0.16%
Jun 30, 2021 0.03%
Mar 31, 2021 0.01%
Dec 31, 2020 0.01%
Sep 30, 2020 0.01%
Jun 30, 2020 0.01%
Mar 31, 2020 0.01%
Dec 31, 2019 0.13%
Sep 30, 2019 -0.02%
Jun 30, 2019 -0.03%
Mar 31, 2019 -0.02%
Dec 31, 2018 -0.02%
Sep 30, 2018 -0.02%
Jun 30, 2018 -0.01%
Mar 31, 2018 -0.02%
Dec 31, 2017 -0.01%
Sep 30, 2017 -0.02%
Jun 30, 2017 -0.02%
Mar 31, 2017 -0.02%
Dec 31, 2016 -0.06%
Sep 30, 2016 0.14%
Jun 30, 2016 -0.63%
Mar 31, 2016 -0.09%
Dec 31, 2015 -0.03%
Sep 30, 2015 -0.02%
Jun 30, 2015 -0.01%
Mar 31, 2015 -0.01%
Dec 31, 2014 -0.01%
Sep 30, 2014 -0.01%
Jun 30, 2014 -0.01%
Mar 31, 2014 -0.01%
Dec 31, 2013 -0.02%
Sep 30, 2013 -0.02%
Jun 30, 2013 -0.02%
Mar 31, 2013 -0.02%
Dec 31, 2012 -0.01%
Sep 30, 2012 -0.02%
Jun 30, 2012 -0.03%
Mar 31, 2012 -0.04%
Dec 31, 2011 -0.05%
Sep 30, 2011 -0.02%